A mechanistic review examining PKC's role in insulin resistance and metabolic syndrome that raises questions about signaling pathways rather than reporting primary experimental evidence or clinical outcomes.
This is a mechanistic review summarizing preclinical evidence linking TMEM97/sigma-2 receptor to endocrine resistance pathways; the source explicitly states evidence remains preclinical and further investigation is needed.
Early mechanistic work combining in vitro cell lines with exploratory Phase I data, investigating a biomarker association rather than clinical outcomes; needs confirmatory studies in larger patient cohorts.